PIMJS
PKO Investment Management Joint-Stock Portfolio holdings
AUM
$931M
1-Year Return
16.38%
This Quarter Return
-3.74%
1 Year Return
+16.38%
3 Year Return
+65%
5 Year Return
+112.48%
10 Year Return
+522.82%
AUM
$738M
AUM Growth
-$78.2M
(-9.6%)
Cap. Flow
-$48.3M
Cap. Flow
% of AUM
-6.54%
Top 10 Holdings %
Top 10 Hldgs %
57.77%
Holding
145
New
2
Increased
25
Reduced
56
Closed
11
Top Buys
| 1 |
Invesco NASDAQ 100 ETF
QQQM
|
$7.37M |
| 2 |
Microsoft
MSFT
|
$3.47M |
| 3 |
Apple
AAPL
|
$2.74M |
| 4 |
Walt Disney
DIS
|
$2.43M |
| 5 |
Tesla
TSLA
|
$2.25M |
Top Sells
| 1 |
iShares Core S&P Small-Cap ETF
IJR
|
$12.3M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
$9.53M |
| 3 |
Amgen
AMGN
|
$6.65M |
| 4 |
AngloGold Ashanti
AU
|
$5.24M |
| 5 |
Exxon Mobil
XOM
|
$2.72M |
Sector Composition
| 1 | Materials | 14.54% |
| 2 | Technology | 10.23% |
| 3 | Healthcare | 7.8% |
| 4 | Energy | 7.74% |
| 5 | Consumer Discretionary | 6.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Teck Resources
TECK
$16B
| $901K | 0.12% |
20,724
| – | – |
|
102
Intuitive Surgical
ISRG
$163B
| $877K | 0.12% |
3,000
+1,000
| +50% | +$292K |
|
103
Zoetis
ZTS
$67.9B
| $870K | 0.12% |
5,000
| – | – |
|
|
MRO
104
DELISTED
Marathon Oil Corporation
MRO
| $803K | 0.11% |
30,000
| – | – |
|
105
Coterra Energy
CTRA
$18.6B
| $784K | 0.11% |
29,000
| – | – |
|
106
Becton Dickinson
BDX
$54.8B
| $776K | 0.11% |
3,000
| – | – |
|
|
DRD
107
DRDGold
DRD
$1.78B
| $754K | 0.1% |
90,814
-30,000
| -25% | -$249K |
|
108
Gilead Sciences
GILD
$140B
| $749K | 0.1% |
10,000
-5,000
| -33% | -$375K |
|
109
NIO
NIO
$13.8B
| $723K | 0.1% |
80,000
-20,000
| -20% | -$181K |
|
|
CGAU
110
Centerra Gold
CGAU
$1.69B
| $716K | 0.1% |
145,000
| – | – |
|
111
Bunge Global
BG
$16.2B
| $693K | 0.09% |
6,400
| – | – |
|
112
First Majestic Silver
AG
$4.43B
| $680K | 0.09% |
131,500
| – | – |
|
|
113
Amgen
AMGN
$151B
| $672K | 0.09% |
2,500
-24,733
| -91% | -$6.65M |
|
114
Tapestry
TPR
$22B
| $633K | 0.09% |
22,000
| – | – |
|
115
NexGen Energy
NXE
$4.34B
| $624K | 0.08% |
103,300
| – | – |
|
116
Idexx Laboratories
IDXX
$51.2B
| $612K | 0.08% |
1,400
+700
| +100% | +$306K |
|
117
PVH
PVH
$4.29B
| $612K | 0.08% |
8,000
| – | – |
|
118
Incyte
INCY
$16.7B
| $607K | 0.08% |
10,500
-3,500
| -25% | -$202K |
|
119
Baxter International
BAX
$12.1B
| $604K | 0.08% |
16,000
| – | – |
|
120
IQVIA
IQV
$31.3B
| $590K | 0.08% |
3,000
+1,500
| +100% | +$295K |
|
121
BioMarin Pharmaceuticals
BMRN
$10.9B
| $531K | 0.07% |
6,000
-3,000
| -33% | -$265K |
|
122
Biogen
BIIB
$20.5B
| $514K | 0.07% |
2,000
+1,200
| +150% | +$308K |
|
123
The Mosaic Company
MOS
$10.4B
| $509K | 0.07% |
14,300
-4,700
| -25% | -$167K |
|
124
Agilent Technologies
A
$36.4B
| $470K | 0.06% |
4,200
| – | – |
|
125
Hudbay
HBM
$4.91B
| $466K | 0.06% |
94,836
| – | – |
|